| Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in hepatitis C: AMBER study R Flisiak, E Janczewska, M Wawrzynowicz‐Syczewska, J Jaroszewicz, ... Alimentary pharmacology & therapeutics 44 (9), 946-956, 2016 | 141 | 2016 |
| Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020 R Flisiak, A Horban, J Jaroszewicz, D Kozielewicz, M Pawłowska, ... Pol Arch Intern Med 130 (4), 352-357, 2020 | 97* | 2020 |
| Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study K Tomasiewicz, A Piekarska, J Stempkowska-Rejek, S Serafińska, ... Expert Review of Anti-infective Therapy 19 (1), 93-100, 2021 | 57 | 2021 |
| Distribution of HCV genotypes in Poland OCWUM w Łodzi, OC Zakaźnych, SS w Chorzowie, WPCI i Hepatologii, ... Przegl Epidemiol 66, 11-16, 2012 | 49 | 2012 |
| Oral antiviral treatments for COVID-19: opportunities and challenges L Rahmah, SO Abarikwu, AG Arero, M Essouma, AT Jibril, A Fal, R Flisiak, ... Pharmacological Reports 74 (6), 1255-1278, 2022 | 48 | 2022 |
| Management of SARS-CoV-2 infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021 R Flisiak, A Horban, J Jaroszewicz, D Kozielewicz, A Mastalerz-Migas, ... Pol Arch Intern Med 131 (5), 487-496, 2021 | 48 | 2021 |
| Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C. W Kryczka, E Brojer, A Kowalska, D Zarebska-Michaluk Medical science monitor: international medical journal of experimental and …, 2001 | 41 | 2001 |
| Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance R Flisiak, D Zarębska-Michaluk, M Rogalska, JA Kryńska, J Kowalska, ... Pharmacological Reports 74 (6), 1279-1285, 2022 | 39 | 2022 |
| Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study R Flisiak, M Łucejko, W Mazur, E Janczewska, H Berak, K Tomasiewicz, ... Advances in medical sciences 62 (2), 387-392, 2017 | 39 | 2017 |
| Management of SARS-CoV-2 infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020 R Flisiak, M Parczewski, A Horban, J Jaroszewicz, D Kozielewicz, ... Polish archives of internal medicine 130 (10), 915-918, 2020 | 38 | 2020 |
| Extrahepatic manifestations associated with chronic hepatitis C infections in Poland DA Zarebska-Michaluk, DM Lebensztejn, WM Kryczka, E Skiba Advances in Medical Sciences 55 (1), 67-73, 2010 | 37 | 2010 |
| Clinical characteristics of hospitalized COVID-19 patients who received at least one dose of COVID-19 vaccine P Rzymski, M Pazgan-Simon, K Simon, T Łapiński, D Zarębska-Michaluk, ... Vaccines 9 (7), 781, 2021 | 36 | 2021 |
| Convalescent plasma transfusion for the treatment of COVID-19—experience from Poland: a multicenter study A Moniuszko-Malinowska, P Czupryna, D Zarębska-Michaluk, ... Journal of Clinical Medicine 10 (1), 28, 2020 | 33 | 2020 |
| Variability in the clinical course of COVID-19 in a retrospective analysis of a large real-world database R Flisiak, P Rzymski, D Zarębska-Michaluk, P Ciechanowski, ... Viruses 15 (1), 149, 2023 | 32 | 2023 |
| Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study R Flisiak, D Zarębska‐Michaluk, E Janczewska, A Staniaszek, A Gietka, ... Journal of Viral Hepatitis 25 (6), 661-669, 2018 | 32 | 2018 |
| Prevalence of HCV genotypes in Poland–the EpiTer study R Flisiak, J Pogorzelska, H Berak, A Horban, I Orłowska, K Simon, ... Clinical and experimental hepatology 2 (4), 144-148, 2016 | 32 | 2016 |
| Demographic and clinical overview of hospitalized COVID-19 patients during the first 17 months of the pandemic in Poland R Flisiak, P Rzymski, D Zarębska-Michaluk, M Rogalska, M Rorat, ... Journal of Clinical Medicine 11 (1), 117, 2021 | 31 | 2021 |
| Real world experience of chronic hepatitis C retreatment with genotype specific regimens in nonresponders to previous interferon-free therapy D Zarębska-Michaluk, I Buczyńska, K Simon, M Tudrujek-Zdunek, ... Canadian Journal of Gastroenterology and Hepatology 2019, 2019 | 31* | 2019 |
| DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C. W Kryczka, E Brojer, A Kalińska, A Urbaniak, D Zarebska-Michaluk Medical Science Monitor: International Medical Journal of Experimental and …, 2001 | 31 | 2001 |
| Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists R Flisiak, A Horban, J Jaroszewicz, D Kozielewicz, M Pawłowska, ... Annex, 0 | 31 | |
